CEL-SCI Co. (NYSEAMERICAN:CVM) was the recipient of a large decrease in short interest in December. As of December 29th, there was short interest totalling 510,101 shares, a decrease of 3.2% from the December 15th total of 526,760 shares. Based on an average daily trading volume, of 161,531 shares, the days-to-cover ratio is currently 3.2 days. Currently, 4.6% of the shares of the stock are short sold.
In other CEL-SCI news, Director Vicente Benjamin Asuncion sold 160,000 shares of the stock in a transaction on Tuesday, October 17th. The stock was sold at an average price of $0.39, for a total transaction of $62,400.00.
Shares of CEL-SCI (NYSEAMERICAN CVM) opened at $1.99 on Thursday. The company has a market capitalization of $23.07, a price-to-earnings ratio of -1.23 and a beta of -1.60. CEL-SCI has a twelve month low of $1.46 and a twelve month high of $4.50.
TRADEMARK VIOLATION WARNING: “CEL-SCI Co. (CVM) Sees Significant Decrease in Short Interest” was originally posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at https://www.com-unik.info/2018/01/11/cel-sci-co-cvm-sees-significant-decrease-in-short-interest.html.
CEL-SCI Company Profile
CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines.
Receive News & Ratings for CEL-SCI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CEL-SCI and related companies with MarketBeat.com's FREE daily email newsletter.